Andr3w024The scoping study will not appear until mid April as others have already suggested.I also obtained confirmation.I do not see the sp collapsing because of this delay as the company and placement investors are bullish on NMR's future.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025